Skip to content

Role of ayurvedic medicine in cancer

Evaluation of certain Ayurvedic formulations in malignancy

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045590
Enrollment
90
Registered
2022-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C801- Malignant (primary) neoplasm, unspecified

Interventions

None listed

Sponsors

Dr Rajeev Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from any diagnosed cancer will be selected for study. 2.Patients of either sex will be selected. 3.Fresh as well as chronic case of malignancy will be taken for study.

Exclusion criteria

Exclusion criteria: 1.Persons not likely to co-operate with the trial regimen due to personal compulsions. 2.Recent history of trauma, fracture, dislocation or other serious secondary ailment etc 3. age other than inclusion criteria

Design outcomes

Primary

MeasureTime frame
Any improvement in subjective criteria eg. improvement in quality of life, appetite,nausea, vomiting,sleep,fatigue, relief in pain and objective criteria eg. improvement in weight and hemoglobin level of patientTimepoint: Total study will be of 90 days, assessment will be done at every 30 days of treatment Base line at 0 days, followed by 30 days, 60 days and lastly on 90 days

Secondary

MeasureTime frame
Significatnt cure of disease or significant improvement in symptoms and signs of patient eg. Any improvement in subjective criteria eg. improvement in quality of life, appetite,nausea, vomiting,sleep,fatigue, relief in pain and objective criteria eg. improvement in weight and hemoglobin level of patientTimepoint: Base line at 0 days, followed by 30 days, 60 days and lastly on 90 days

Countries

India

Contacts

Public ContactDr Rajeev Kumar

Uttarakhand Ayurveda University

mrityunjaymission@gmail.com9897523499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026